Market Cap | 679.43M | P/E | 9.89 | EPS this Y | 20.00% | Ern Qtrly Grth | 306.90% |
Income | 264.72M | Forward P/E | 9.89 | EPS next Y | 25.00% | 50D Avg Chg | -20.00% |
Sales | 2.73B | PEG | - | EPS past 5Y | - | 200D Avg Chg | -28.00% |
Dividend | N/A | Price/Book | 0.15 | EPS next 5Y | - | 52W High Chg | -47.00% |
Recommedations | 1.60 | Quick Ratio | 3.49 | Shares Outstanding | 288.75M | 52W Low Chg | 84.00% |
Insider Own | 0.87% | ROA | 1.29% | Shares Float | 1.43B | Beta | -0.27 |
Inst Own | 3.13% | ROE | 5.49% | Shares Shorted/Prior | 699.60K/804.84K | Price | 1.78 |
Gross Margin | 53.62% | Profit Margin | 9.71% | Avg. Volume | 813,804 | Target Price | 1.70 |
Oper. Margin | 7.74% | Earnings Date | Sep 4 | Volume | 691,586 | Change | -2.73% |
Waterdrop Inc., through its subsidiaries, provides online insurance brokerage services to match and connect users with related insurance products underwritten by insurance companies in the People's Republic of China. The company offers short-term and long-term health and life insurance products and services. It also operates a medical crowdfunding platform; and E-Find patient recruitment, a digital platform that helps pharmaceutical companies to find matches for clinical trials. Waterdrop Inc. was founded in 2016 and is headquartered in Beijing, the People's Republic of China.
Goldman Sachs | Buy | Sep 8, 23 |
Goldman Sachs | Buy | Dec 7, 22 |
Morgan Stanley | Overweight | Sep 16, 22 |
Morgan Stanley | Equal-Weight | Mar 25, 22 |
CLSA | Outperform | Dec 2, 21 |
Morgan Stanley | Overweight | Jun 2, 21 |
CLSA | Buy | Jun 1, 21 |
Goldman Sachs | Buy | Jun 1, 21 |
B of A Securities | Buy | Jun 1, 21 |